Home
About Us
News
R&D
Manufacture
Products
Culture

Qingfeng Pharmaceutical Group

中文
English
Providing sustainable and high-quality service for human health
Become a leading provider of medical health products and service
Innovating, Efficiency, Striving, Sharing
魔方导航
About Us

News

R&D

Manufactur...

Products

Culture

News
‍
Qingfeng Pharmaceutical Group Lenvatinib Mesylate capsule was approved for listing
Qingfeng was listed as the "best industrial enterprise in China's pharmaceutical R & D product line"
Company News
2021/08/03
Qingfeng Pharma. new method for synthesizing lacosamide won the Chinese patent Excellence Award
Company News
2021/07/06
R&D
Innovation Platform
Innovation Platform
R&D Results
R&D Results
R&D Talents
R&D Talents
Research Cooperation
Research Cooperation
Home Page
Member Center
PC version
English
中文
English


©2020-2022 Qingfeng Group All rights reserved


PC version Fanke Construction Station provides technical support
赣ICP备2022007616号-1 赣公网安备 36070202000018号